Aptar Pharma to Showcase Connected Health Innovations at DDL 2017

Aptar Pharma is proud to be a Silver Sponsor at the upcoming DDL Conference 2017 in Edinburgh, Scotland, from December 6-8.

DDL is one of Europe’s premier conference and industry exhibitions dedicated to pulmonary and nasal drug delivery. Attended by scientists, academics, clinicians, regulatory and industry specialists involved in the development of inhalation medicines, DDL is a key venue for learning about the latest innovations in the drug delivery sector, and provides a unique platform to present new technologies.

In addition to being a Silver Sponsor, Aptar Pharma will be participating in two scientific poster presentations at this year’s conference. In addition, Aptar Pharma will feature an interactive booth, located at stand #244, where our team of experts will showcase our innovative range of MDIs, DPIs and BAIs, and demonstrate how we can accelerate speed-to-market by assisting customers from concept through to regulatory submission.

While at our stand, explore our Connectivity Hub, dedicated to the growing field of c-Devices,  and gain insight into our range of add-on and integrated c-Devices. These intuitive devices feature fully-connected functionality and software integration, to improve patient health outcomes.

Connect with Aptar Pharma at DDL. If you still need to register, visit https://aerosol-soc.com/events/ddl2017/.